Form 4: Amedisys Acquired by UnitedHealth Group for $101/Share

Amedisys, Inc. director Vickie L. Capps reports disposition of shares following the company's acquisition by UnitedHealth Group for $101 per share in cash.

Summary

• Amedisys, Inc. was acquired by UnitedHealth Group Incorporated on August 14, 2025.
• The acquisition was executed through a merger where Aurora Holdings Merger Sub Inc., a wholly owned subsidiary of UnitedHealth Group, merged with Amedisys.
• Amedisys survived the merger as a wholly owned subsidiary of UnitedHealth Group.
• Each outstanding share of Amedisys common stock was converted into the right to receive $101 per share in cash, without interest and less any applicable withholding tax.
• The transaction included the conversion of 1,690 time-based Restricted Stock Units (RSUs) into the right to receive the $101 per share cash consideration.
• Director Vickie L. Capps disposed of 9,818 shares of Amedisys Common Stock as a result of the merger, resulting in 0 shares beneficially owned post-transaction.

Sentiment

Score: 7

Explanation: The sentiment is positive for Amedisys shareholders who received a cash premium for their shares, indicating a successful exit. For the company itself, it marks the end of its independent public trading status, which is a neutral to slightly negative event from a standalone perspective, but a strategic move for the acquirer. The overall sentiment reflects the successful completion of a significant corporate transaction.

Positives

• Shareholders of Amedisys received a cash consideration of $101 per share, providing a clear exit value for their investment.
• The completion of the merger provides certainty for Amedisys shareholders regarding the previously announced acquisition terms.

Negatives

• Amedisys, Inc. ceased to be an independent publicly traded entity, becoming a wholly owned subsidiary of UnitedHealth Group.

Risks

• No new risks are identified in this Form 4 filing, as it reports on a completed transaction. Prior risks associated with the merger, such as regulatory approvals or financing, have been resolved.

Future Outlook

This Form 4 reports on a completed transaction; therefore, it does not provide forward-looking statements or guidance for Amedisys as an independent entity. Amedisys is now a wholly owned subsidiary of UnitedHealth Group.

Industry Context

The acquisition of Amedisys by UnitedHealth Group reflects the ongoing consolidation trend within the U.S. healthcare sector, particularly in the home health and hospice care segments. Larger integrated healthcare providers are seeking to expand their service offerings and care delivery models, including in-home care, to meet evolving patient needs and potentially achieve greater efficiencies.

Comparison to Industry Standards

• The acquisition price of $101 per share for Amedisys aligns with valuations seen in other recent healthcare sector mergers and acquisitions, particularly for companies with strong positions in specialized care segments like home health and hospice.
• Comparable transactions in the home health and hospice space include LHC Group's acquisition by Optum (a UnitedHealth Group subsidiary) for approximately $5.4 billion, which valued LHC Group at a premium, and the acquisition of AccentCare by Advent International, indicating a strong appetite for these assets.
• The cash consideration structure is common for strategic acquisitions where the acquiring entity seeks full ownership and integration, providing immediate liquidity to the target company's shareholders.

Stakeholder Impact

• Shareholders of Amedisys received a cash payout, concluding their investment in the company.
• Employees of Amedisys will now be part of UnitedHealth Group, potentially experiencing changes in corporate culture, benefits, and organizational structure.
• Customers (patients) of Amedisys may see changes in service delivery or integration with UnitedHealth Group's broader healthcare network.
• Suppliers and creditors will now interact with Amedisys as a subsidiary of UnitedHealth Group, potentially impacting existing contracts or relationships.

Next Steps

• Amedisys will operate as a wholly owned subsidiary of UnitedHealth Group.
• Integration of Amedisys's operations into UnitedHealth Group's broader healthcare services.

Key Dates

Keywords

Amedisys, UnitedHealth Group, Merger, Acquisition, Healthcare, Home Health, Hospice, Form 4, SEC Filing, Stock Transaction, Cash Consideration